Published in Br J Pharmacol on March 01, 2012
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol (2012) 1.26
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim Biophys Acta (2011) 1.16
Amyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2. PLoS One (2012) 0.92
Calcium channel blockers and dementia. Br J Pharmacol (2013) 0.91
Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology. Curr Alzheimer Res (2013) 0.85
P/Q-type calcium channel modulators. Br J Pharmacol (2012) 0.84
Ablation of Ca(V)2.1 voltage-gated Ca²⁺ channels in mouse forebrain generates multiple cognitive impairments. PLoS One (2013) 0.80
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases. Curr Neuropharmacol (2013) 0.80
Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses. J Neurosci (2015) 0.79
Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease. Neurosci Biobehav Rev (2016) 0.78
Functional and structural effects of amyloid-β aggregate on Xenopus laevis oocytes. Mol Cells (2012) 0.76
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (2002) 19.36
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol (2007) 17.69
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron (1992) 10.25
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci (2004) 9.73
Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci (2007) 8.27
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell (2010) 7.52
Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci (2007) 6.27
Patch clamp measurements on Xenopus laevis oocytes: currents through endogenous channels and implanted acetylcholine receptor and sodium channels. Pflugers Arch (1986) 6.15
Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron (2004) 4.88
Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem (2007) 3.35
Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci (2008) 3.21
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06
Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J Neurosci (2005) 2.57
Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci (2009) 2.31
Localization and functional properties of a rat brain alpha 1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proc Natl Acad Sci U S A (1994) 2.23
Distinctive biophysical and pharmacological properties of class A (BI) calcium channel alpha 1 subunits. Neuron (1993) 2.14
The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol (2005) 1.88
Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol (2002) 1.60
Presynaptic Ca2+ channels--integration centers for neuronal signaling pathways. Trends Neurosci (2006) 1.58
Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev (2006) 1.57
Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J Neurosci (2008) 1.54
beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem (2006) 1.50
ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol Dis (2005) 1.30
Systematic identification of splice variants in human P/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation. J Neurosci (2002) 1.30
beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci (2000) 1.25
Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience (2007) 1.24
Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. J Neurosci (2010) 1.20
Cloning and functional expression of GABA(B) receptors from Drosophila. Eur J Neurosci (2001) 1.16
Amyloid β peptide oligomers directly activate NMDA receptors. Cell Calcium (2011) 1.15
beta subunits influence the biophysical and pharmacological differences between P- and Q-type calcium currents expressed in a mammalian cell line. Proc Natl Acad Sci U S A (1997) 1.02
Rat brain N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Science (1987) 1.01
Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo. Neuroreport (2004) 1.01
Novel Cav2.1 splice variants isolated from Purkinje cells do not generate P-type Ca2+ current. J Biol Chem (2001) 0.98
The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels. J Neurochem (2008) 0.95
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle. J Pharmacol Exp Ther (1986) 0.89
Voltage-dependent modulation of cardiac calcium channel current by optical isomers of Bay K 8644: implications for channel gating. Circ Res (1987) 0.89
Inhibitors of GlyT1 affect glycine transport via discrete binding sites. Mol Pharmacol (2008) 0.88
The binding of kappa-Conotoxin PVIIA and fast C-type inactivation of Shaker K+ channels are mutually exclusive. Biophys J (2004) 0.84
Kinetic modulation of guinea-pig cardiac L-type calcium channels by fendiline and reversal of the effects of Bay K 8644. Br J Pharmacol (1992) 0.81
Oocytes as an expression system for studying receptor/channel targets of drugs and pesticides. Methods Mol Biol (2006) 0.80
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A (1993) 5.23
Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem (1983) 3.91
Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem (2001) 2.32
Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer (1983) 2.30
Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br J Pharmacol (1989) 2.00
Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol (1993) 1.81
European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect (2000) 1.80
Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis (1996) 1.65
Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clin Exp Allergy (2013) 1.50
Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A (1981) 1.48
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Ann Allergy Asthma Immunol (1999) 1.46
Optimization of isolated hyperthermic limb perfusion. World J Surg (1993) 1.44
Inducibility of human beta-interferon gene in mouse L-cell clones. Nature (1982) 1.43
Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol (1985) 1.42
Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor. EMBO J (1987) 1.40
Biliary complications related to laparoscopic cholecystectomies: radiologic diagnosis and management. Surg Laparosc Endosc (1992) 1.39
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J Exp Med (1993) 1.35
The structure of a thirty-six kilobase region of the human chromosome including the fibroblast interferon gene IFN-beta. Nucleic Acids Res (1981) 1.33
Correlation between human papillomavirus (HPV) type and histology of warts. J Invest Dermatol (1982) 1.25
Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol (1985) 1.24
A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis. Acta Psychiatr Scand (1975) 1.24
Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J Neurochem (1993) 1.22
Bmp-2 downstream targets in mesenchymal development identified by subtractive cloning from recombinant mesenchymal progenitors (C3H10T1/2). Dev Dyn (1998) 1.21
Phospholipid-hydroperoxide glutathione peroxidase. Genomic DNA, cDNA, and deduced amino acid sequence. J Biol Chem (1994) 1.20
Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur J Pharmacol (1981) 1.19
European guideline for the management of anogenital warts. Int J STD AIDS (2001) 1.18
Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol (1986) 1.17
Effects of maternal deprivation on the ACTH stress response in the infant rat. Neuroendocrinology (1993) 1.14
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol (2000) 1.14
Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Commun (1982) 1.11
The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recenti Prog Med (1989) 1.10
Enhancement of translational efficiency by the Escherichia coli atpE translational initiation region: its fusion with two human genes. Gene (1986) 1.10
The T-body approach: potential for cancer immunotherapy. Springer Semin Immunopathol (1996) 1.10
Improved processing technique for renal biopsies for light microscopy. J Clin Pathol (1970) 1.08
Characterization of human papillomavirus 3 in warts of a renal allograft patient. J Invest Dermatol (1979) 1.08
Thyroid-dependent alterations of myocardial adrenoceptors and adrenoceptor-mediated responses in the rat. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.07
BMP signaling pathways in cartilage and bone formation. Crit Rev Eukaryot Gene Expr (2001) 1.05
Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J Pharmacol Exp Ther (1983) 1.05
Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a malignant melanoma. Int J Cancer (1986) 1.04
Longitudinal studies of schizophrenic patients. Schizophr Bull (1980) 1.04
Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart. Br J Pharmacol (1994) 1.02
Characterization of a ts beta' mutant RNA polymerase of Escherichia coli. Mol Gen Genet (1976) 1.01
Interaction of plakophilins with desmoplakin and intermediate filament proteins: an in vitro analysis. J Cell Sci (2000) 1.01
Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol Psychiatry (1994) 0.99
Truncation mutagenesis of the non-alpha-helical carboxyterminal tail domain of vimentin reveals contributions to cellular localization but not to filament assembly. Eur J Cell Biol (1995) 0.98
Systemic treatment of condylomata acuminata with recombinant interferon-alpha-2a: low-dose superior to the high-dose regimen. Chemotherapy (1986) 0.98
New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology (Berl) (1999) 0.97
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp Ther (2001) 0.97
Functional studies on alpha 1-adrenoceptor subtypes mediating inotropic effects in rat right ventricle. Br J Pharmacol (1994) 0.95
Dopamine D(3) receptors and salt-dependent hypertension. J Am Soc Nephrol (2001) 0.95
In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent. Arzneimittelforschung (1995) 0.95
Altered energy metabolism in anorexia nervosa. Psychoneuroendocrinology (2001) 0.95
The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. J Bone Miner Res (2000) 0.95
Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed? Med Microbiol Immunol (2003) 0.95
Developmental expression analysis of murine autotaxin (ATX). Mech Dev (1999) 0.94
Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. Eur J Pharmacol (2000) 0.94
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol (2006) 0.93
Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.93
Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutat Res (1991) 0.93
Spin-lattice relaxation (T1) times of cerebral white matter in multiple sclerosis. Magn Reson Med (1986) 0.93
[Schizophrenia. Clinical course and social psychiatric long term examinations of schizophrenic patients hospitalized in Bonn from 1945-1959]. Monogr Gesamtgeb Psychiatr Psychiatry Ser (1979) 0.93
DNA microarray technology and its applications in dermatology. Exp Dermatol (2004) 0.93
Successful treatment of condylomata acuminata and bowenoid papulosis with subcutaneous injections of low-dose recombinant interferon-alpha. Arch Dermatol (1986) 0.93
Alpha 1-adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sites. J Pharm Pharmacol (1989) 0.92
Parathyroid hormone enhances early and suppresses late stages of osteogenic and chondrogenic development in a BMP-dependent mesenchymal differentiation system (C3H10T1/2). J Bone Miner Res (1997) 0.92
Could inflammatory arthritis be triggered by progenitor cells in the joints? Ann Rheum Dis (2002) 0.92
[Sensory disorders in schizophrenia]. Arch Psychiatr Nervenkr (1970) (1972) 0.92
Psychopathology of basic stages of schizophrenia in view of formal thought disturbances. Psychopathology (1985) 0.91
Basic symptoms in schizophrenic and affective psychoses. Psychopathology (1989) 0.91
Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma. Cell Growth Differ (2001) 0.91
Effects of antidepressants on monoamine transporters. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.90
Covalent enzyme-RNA complex: a tRNA modification that prevents a covalent enzyme interaction also prevents aminoacylation. Proc Natl Acad Sci U S A (1985) 0.90
[3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex. Eur J Pharmacol (1985) 0.90
Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res (1990) 0.90
Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney. Neurobiol Aging (1981) 0.89
Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. Eur J Pharmacol (1993) 0.89
Reduction of cardiac outward currents by alpha-1 adrenoceptor stimulation: a subtype-specific effect? J Pharmacol Exp Ther (1991) 0.89
Amisulpride: from animal pharmacology to therapeutic action. Int Clin Psychopharmacol (1997) 0.89
Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes. Neuroscience (2009) 0.89
Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol (1993) 0.88
Culture of primary human gingival fibroblasts on biodegradable membranes. Biomaterials (2002) 0.88
Seroepidemiologic studies of bovine papillomavirus infections. J Natl Cancer Inst (1979) 0.88
[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. Eur J Pharmacol (1985) 0.88
The preclinical pharmacologic profile of tiapride. Eur Psychiatry (2001) 0.87
[Long-term course of schizophrenic psychoses. Joint results of two studies]. Nervenarzt (1976) 0.87
Effects of thyroid hormone deficiency on pre- and postsynaptic noradrenergic mechanisms in the rat cerebral cortex. Arch Int Pharmacodyn Ther (1980) 0.87
Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour. Pharmacol Res (2008) 0.87
Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology (1998) 0.86
Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity. J Cardiovasc Pharmacol (1987) 0.85
Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox. J Neurochem (1987) 0.85
Effect of oral aromatic retinoid (Ro 10-9359) on human papilloma virus-2-induced common warts. Dermatologica (1983) 0.85
Molecular and pharmacological characterization of native cortical gamma-aminobutyric acidA receptors containing both alpha1 and alpha3 subunits. J Biol Chem (1996) 0.85
[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res (1982) 0.85
B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma. Dermatology (1996) 0.85
Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes. J Pharmacol Exp Ther (1984) 0.85
Pharmacological studies on synthetic flavonoids: comparison with diazepam. Neuropharmacology (1999) 0.85
Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats. J Pharmacol Exp Ther (2010) 0.85